← FDA Drug Approvals (Drugs@FDA)
POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45%
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FRESENIUS KABI USA · Approved 2021-03-09
Drug application
- FDA Application #
ANDA213523- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- POTASSIUM CHLORIDE 40MEQ IN DEXTROSE 5% AND SODIUM CHLORIDE 0.45%
- Generic name
- DEXTROSE MONOHYDRATE, SODIUM CHLORIDE, AND POTASSIUM CHLORIDE
- Active ingredients
- DEXTROSE; POTASSIUM CHLORIDE; SODIUM CHLORIDE
- Dosage form
- INJECTABLE
- Route
- INJECTION
- Marketing status
- Prescription
- Sponsor
- FRESENIUS KABI USA
- Manufacturer
- Fresenius Kabi USA, LLC
- First approval
- 2021-03-09
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown